MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, GLUE has $736,428K in assets. $214,512K in debts. $159,859K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
953.81%
Quick Ratio
953.81%
Cash Ratio
225.04%
Debt to Asset Ratio
29.13%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue, net of current
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
159,859 129,883 208,343 69,429
Marketable securities
506,361 247,221 182,915 221,165
Collaboration receivable
0 7,000 --
Other receivables
4,609 4,600 4,965 2,370
Prepaid expenses and other current assets
6,718 4,481 5,594 6,501
Total current assets
677,547 393,185 401,817 299,465
Total property and equipment, at cost
58,053 53,599 53,122 -
Less accumulated depreciation
29,644 27,613 25,524 -
Property and equipment, net
28,409 25,986 27,598 29,052
Operating lease right-of-use assets
24,693 24,386 25,065 25,674
Restricted cash
4,947 4,954 4,950 4,950
Other long-term assets
832 148 411 445
Total assets
736,428 448,659 459,841 359,586
Accounts payable
7,900 3,550 14,509 5,581
Accrued expenses and other current liabilities
25,594 26,694 17,902 13,767
Current deferred revenue
33,059 29,571 24,791 18,410
Current portion of operating lease liability
4,483 4,397 4,241 4,094
Total current liabilities
71,036 64,212 61,443 41,852
Deferred revenue, net of current
103,635 111,332 111,894 8,059
Defined benefit plan liability
5,260 5,265 4,740 4,558
Operating lease liability, net of current
34,581 34,794 35,927 37,037
Total liabilities
214,512 215,603 214,004 91,506
Common stock, 0.0001 par value 500,000,000 shares authorized, 84,321,705 and 65,543,723 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
8 7 6 6
Additional paid-in capital
1,048,371 714,090 680,157 675,445
Accumulated other comprehensive loss
-4,746 -3,827 -3,247 -3,373
Accumulated deficit
-521,717 -477,214 -431,079 -403,998
Total stockholders' equity
521,916 233,056 245,837 268,080
Total liabilities and stockholders' equity
736,428 448,659 459,841 359,586
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$506,361K Cash and cashequivalents$159,859K Prepaid expenses andother current assets$6,718K Other receivables$4,609K Total property andequipment, at cost$58,053K Total current assets$677,547K Property and equipment,net$28,409K Operating leaseright-of-use assets$24,693K Restricted cash$4,947K Other long-termassets$832K Less accumulateddepreciation$29,644K Total assets$736,428K Total liabilities andstockholders' equity$736,428K Total stockholders'equity$521,916K Total liabilities$214,512K Accumulated deficit-$521,717K Accumulated othercomprehensive loss-$4,746K Additional paid-in capital$1,048,371K Deferred revenue, net ofcurrent$103,635K Total currentliabilities$71,036K Operating leaseliability, net of current$34,581K Defined benefit planliability$5,260K Common stock, 0.0001par value...$8K Current deferredrevenue$33,059K Accrued expenses andother current...$25,594K Accounts payable$7,900K Current portion ofoperating lease liability$4,483K

Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics, Inc. (GLUE)